Lenny Moise

Lenny Moise, PhD, serves as the Vice President of Research at SeromYx Systems. He earned his PhD from the Department of Molecular and Cellular Biology and Biochemistry at Brown University in Providence, RI, in 2002. His doctoral research in Dr. Edward Hawrot’s laboratory focused on structure-function relationships of snake neurotoxin interactions with the nicotinic acetylcholine receptor. Following his PhD, Dr. Moise pursued postdoctoral training at Brown University, where he delved into the functional analysis of toxin binding sites engineered into toxin-insensitive ion channels. In 2005, he joined Dr. Anne De Groot’s laboratory at Brown University as an Instructor in Medicine in the Department of Medicine (Infectious Disease), where his research centered on T-cell epitope-driven vaccination and protein therapeutic immunogenicity. He joined EpiVax in Providence, RI, in 2006, where he served as the Director of Vaccine Research until 2022. Over this time, he led innovative T cell epitope-driven vaccine development projects, employing a comprehensive genomes-to-vaccine approach that combines immunoinformatic and immunologic methodologies. He also dedicated his efforts to the de-immunization of protein therapeutics through epitope modification. In 2008, Dr. Moise accepted a part-time appointment as Assistant Research Professor in the Department of Cell and Molecular Biology at the University of Rhode Island, becoming a founding faculty member of the URI Institute for Immunology and Informatics, and was promoted to Associate Research Professor in 2014. Additionally, from 2020 to 2022, he was a part-time Research Professor in the Center for Vaccines and Immunology at the University of Georgia. Dr. Moise joined SeromYx in 2022, where he assumed the responsibilities of driving the scientific development of the Systems Serology platform and overseeing the management of both commercial and internally driven research projects.